| Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? |
224 |
| The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer |
68 |
| Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer |
57 |
| Lipid metabolism reprogramming and its potential targets in cancer |
42 |
| Boron delivery agents for neutron capture therapy of cancer |
40 |
| When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance |
31 |
| A realistic appraisal of boron neutron capture therapy as a cancer treatment modality |
30 |
| Mucinous colorectal adenocarcinoma: clinical pathology and treatment options |
25 |
| Precision medicine becomes reality-tumor type-agnostic therapy |
24 |
| Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma |
21 |
| The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer |
18 |
| China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy |
17 |
| Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells |
16 |
| PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer |
15 |
| Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer |
15 |
| Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety |
15 |
| National trend of gastric cancer mortality in China (2003-2015): a population-based study |
14 |
| Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives |
14 |
| The immune landscape of esophageal cancer |
14 |
| Metabolic recoding of epigenetics in cancer |
13 |
| Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance |
13 |
| DUXAP a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2 |
12 |
| DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways |
12 |
| Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor |
12 |
| Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study |
10 |
| Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy |
10 |
| Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis |
10 |
| Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations |
10 |
| Age exerts a continuous effect in the outcomes of Asian breast cancer patients treated with breast-conserving therapy |
9 |
| Parkinson's disease-associated protein Parkin: an unusual player in cancer |
9 |
| Cancer cell reprogramming: a promising therapy converting malignancy to benignity |
9 |
| Incidence trends and survival prediction of hepatoblastoma in children: a population-based study |
9 |
| Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial |
8 |
| Nonmetabolic functions of metabolic enzymes in cancer development |
8 |
| Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis |
8 |
| A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy |
8 |
| Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma |
7 |
| The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial-mesenchymal transition, and immune response |
7 |
| Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget's disease with curative responses |
7 |
| Snail promotes metastasis of nasopharyngeal carcinoma partly by down-regulating TEL2 |
7 |
| The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer |
6 |
| Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways |
6 |
| Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study |
6 |
| Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies |
6 |
| TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis |
6 |
| Laparoscopic versus open pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score matching analysis |
6 |
| First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution's clinical practice experience |
6 |
| Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation |
6 |
| Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis |
6 |
| Azithromycin enhances anticancer activity of TRAIL by inhibiting autophagy and up-regulating the protein levels of DR4/5 in colon cancer cells in vitro and in vivo |
6 |
